Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Calgary

$135,000.00

Pannexin-1 channels as therapeutic targets in post-stroke neuroinflammation

EF 2014-15

Résumé
Approximately 7 million people world-wide are killed from a stroke annually and less than 10% of victims receive clinically approved therapies to alleviate stroke burden. Currently, the only approved stroke therapy is intravenous administration of an enzyme that degrades the blood clot occluding the cerebral vasculature. This therapy is only effective within the first 3-4 hours following the onset of stroke and as a result there is a timely need for new therapeutic strategies to combat this debilitating trauma. One promising avenue is targeting the neuroinflammatory response that manifests following ischemic stroke. This pathophysiological process involves the activation and recruitment of immune cells in the brain which can become toxic to neurons. Resident immune cells called microglia sense danger signals in the ischemic region of the brain, one of the most potent being the cell's main energy source, ATP. ATP is normally retained in the interior of cells; however, during ischemic stroke neurons may release large quantities of this molecule and activate microglia, promoting breakdown of the blood-brain-barrier and invasion of circulating inflammatory cells, further exacerbating neuronal death. Recently, our laboratory discovered a central role for the large pore ion channel Pannexin-1 (Panx1) in neuronal death in pre-clinical stroke models. Pannexin-1 channels are a prominent ATP-release pathway in the brain and may therefore constitute a potential target for alleviation of post-stroke neuroinflammation. Our research proposal is aimed at investigating the function of neural Panx1 channels in the activation of microglia, invasion of systemic immune cells and neuronal death during stroke. This project will significantly expand the scientific understanding of neuroinflammation in stroke and provide new molecular targets to therapeutically reduce cognitive deficits from stroke.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
318406
Name
Lohman Alexander W
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Pannexin-1 channels as therapeutic targets in post-stroke neuroinflammation
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Atp; Multi-Photon Fluorescence Microscopy; Neuroinflammation; Optogenetics; Pannexin-1; Stroke
Abstract
Approximately 7 million people world-wide are killed from a stroke annually and less than 10% of victims receive clinically approved therapies to alleviate stroke burden. Currently, the only approved stroke therapy is intravenous administration of an enzyme that degrades the blood clot occluding the cerebral vasculature. This therapy is only effective within the first 3-4 hours following the onset of stroke and as a result there is a timely need for new therapeutic strategies to combat this debilitating trauma. One promising avenue is targeting the neuroinflammatory response that manifests following ischemic stroke. This pathophysiological process involves the activation and recruitment of immune cells in the brain which can become toxic to neurons. Resident immune cells called microglia sense danger signals in the ischemic region of the brain, one of the most potent being the cell's main energy source, ATP. ATP is normally retained in the interior of cells; however, during ischemic stroke neurons may release large quantities of this molecule and activate microglia, promoting breakdown of the blood-brain-barrier and invasion of circulating inflammatory cells, further exacerbating neuronal death. Recently, our laboratory discovered a central role for the large pore ion channel Pannexin-1 (Panx1) in neuronal death in pre-clinical stroke models. Pannexin-1 channels are a prominent ATP-release pathway in the brain and may therefore constitute a potential target for alleviation of post-stroke neuroinflammation. Our research proposal is aimed at investigating the function of neural Panx1 channels in the activation of microglia, invasion of systemic immune cells and neuronal death during stroke. This project will significantly expand the scientific understanding of neuroinflammation in stroke and provide new molecular targets to therapeutically reduce cognitive deficits from stroke.
Competitiondate
201411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lohman, Alexander W
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~